Resource Category: Presentations

A synthetic cytokine receptor platform for producing cytotoxic innate lymphocytes as “off-the-shelf” cancer therapeutics

Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeutics.

Synthetic cytokine receptor enables enhanced persistence and next-generation manufacturing of iPSC-derived allogeneic CAR cells

A scalable and flexible future for gene therapy production

Integrating in vivo Transduction of CARs with Universal Solid Tumor Targeting Molecules